logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Condon, Richard Michael
    Director born in August 1976
    Individual (11 offsprings)
    Officer
    icon of calendar 2023-04-28 ~ now
    OF - Director → CIF 0
  • 2
    May, Jonathan Charles
    Director born in April 1970
    Individual (13 offsprings)
    Officer
    icon of calendar 2020-06-15 ~ now
    OF - Director → CIF 0
  • 3
    Buckley, Gary David
    Director born in February 1986
    Individual (13 offsprings)
    Officer
    icon of calendar 2020-06-15 ~ now
    OF - Director → CIF 0
    Buckley, Gary David
    Individual (13 offsprings)
    Officer
    icon of calendar 2020-06-15 ~ now
    OF - Secretary → CIF 0
  • 4
    icon of address102, High Street, Godalming, England
    Active Corporate (3 parents, 1 offspring)
    Equity (Company account)
    4,689,997 GBP2023-12-31
    Person with significant control
    icon of calendar 2019-09-19 ~ now
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 13
  • 1
    Hill, Jane
    Sales Director born in February 1976
    Individual (2 offsprings)
    Officer
    icon of calendar 2009-05-14 ~ 2011-02-28
    OF - Director → CIF 0
  • 2
    Kadis, Dimitris
    Born in May 1976
    Individual (1 offspring)
    Officer
    icon of calendar 2010-01-11 ~ 2010-10-11
    OF - Director → CIF 0
  • 3
    Green, Julie Anne
    Pharmaceutical Operations born in May 1957
    Individual
    Officer
    icon of calendar 2009-06-22 ~ 2013-11-21
    OF - Director → CIF 0
  • 4
    Fraser-pye, Graham Julian
    Pharmaceuticals born in March 1968
    Individual (17 offsprings)
    Officer
    icon of calendar 2009-06-22 ~ 2021-09-03
    OF - Director → CIF 0
  • 5
    Damanakis, Emmanouil
    Attorney At Law born in April 1955
    Individual
    Officer
    icon of calendar 2010-11-15 ~ 2014-12-09
    OF - Director → CIF 0
  • 6
    Kahan, Barbara
    Director born in June 1931
    Individual (463 offsprings)
    Officer
    icon of calendar 2009-02-24 ~ 2009-02-24
    OF - Director → CIF 0
  • 7
    Podolsky, Craig
    Investment Professional born in February 1981
    Individual (10 offsprings)
    Officer
    icon of calendar 2020-06-15 ~ 2021-09-03
    OF - Director → CIF 0
  • 8
    Roberts, Debra Joy
    Financial Director born in January 1962
    Individual (1 offspring)
    Officer
    icon of calendar 2013-11-12 ~ 2020-05-31
    OF - Director → CIF 0
    Roberts, Debra Joy
    Individual (1 offspring)
    Officer
    icon of calendar 2013-11-12 ~ 2020-05-31
    OF - Secretary → CIF 0
  • 9
    Roberts, Mark Derek
    Company Director born in August 1967
    Individual (12 offsprings)
    Officer
    icon of calendar 2014-12-09 ~ 2021-09-03
    OF - Director → CIF 0
  • 10
    Douglas, James
    Director born in July 1971
    Individual
    Officer
    icon of calendar 2009-02-24 ~ 2009-05-14
    OF - Director → CIF 0
  • 11
    Jacobson, Ian
    Chief Executive born in March 1960
    Individual (12 offsprings)
    Officer
    icon of calendar 2014-12-09 ~ 2021-09-03
    OF - Director → CIF 0
  • 12
    icon of address102, High Street, Godalming, England
    Liquidation Corporate (7 parents, 1 offspring)
    Equity (Company account)
    12,069,492 GBP2020-12-31
    Person with significant control
    2019-09-04 ~ 2019-09-19
    PE - Ownership of voting rights - 75% or more with control over the trustees of a trust → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
  • 13
    icon of address102, High Street, Godalming, England
    Liquidation Corporate (8 parents, 1 offspring)
    Equity (Company account)
    2,552,085 GBP2020-12-31
    Person with significant control
    2016-04-06 ~ 2019-09-04
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

ASPIRE PHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Cost of Sales
-70,398,278 GBP2024-01-01 ~ 2024-12-31
-63,237,459 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-20,167,762 GBP2024-01-01 ~ 2024-12-31
-15,655,697 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
451,410 GBP2024-01-01 ~ 2024-12-31
100,320 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
24,929,242 GBP2024-01-01 ~ 2024-12-31
20,320,873 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
23,092,481 GBP2024-01-01 ~ 2024-12-31
19,533,952 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Goodwill
9,985,837 GBP2024-12-31
5,120,668 GBP2023-12-31
Other
14,141,067 GBP2024-12-31
8,764,324 GBP2023-12-31
Intangible Assets
24,126,904 GBP2024-12-31
13,884,992 GBP2023-12-31
Property, Plant & Equipment
167,281 GBP2024-12-31
173,441 GBP2023-12-31
Fixed Assets - Investments
25,983 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets
24,320,168 GBP2024-12-31
14,058,433 GBP2023-12-31
Debtors
32,679,942 GBP2024-12-31
30,955,575 GBP2023-12-31
Cash at bank and in hand
8,506,998 GBP2024-12-31
9,678,345 GBP2023-12-31
Current Assets
72,044,348 GBP2024-12-31
63,239,714 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-29,463,201 GBP2024-12-31
-27,770,453 GBP2023-12-31
Net Current Assets/Liabilities
42,581,147 GBP2024-12-31
35,469,261 GBP2023-12-31
Total Assets Less Current Liabilities
66,901,315 GBP2024-12-31
49,527,694 GBP2023-12-31
Net Assets/Liabilities
65,800,197 GBP2024-12-31
48,507,716 GBP2023-12-31
Equity
Called up share capital
2,600,003 GBP2024-12-31
2,600,003 GBP2023-12-31
2,600,003 GBP2022-12-31
Share premium
899,998 GBP2024-12-31
899,998 GBP2023-12-31
899,998 GBP2022-12-31
Retained earnings (accumulated losses)
62,300,196 GBP2024-12-31
45,007,715 GBP2023-12-31
44,716,950 GBP2022-12-31
Equity
65,800,197 GBP2024-12-31
48,507,716 GBP2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
23,092,481 GBP2024-01-01 ~ 2024-12-31
19,533,952 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
Retained earnings (accumulated losses)
-19,243,187 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
-5,800,000 GBP2024-01-01 ~ 2024-12-31
Audit Fees/Expenses
27,000 GBP2024-01-01 ~ 2024-12-31
26,000 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
1002024-01-01 ~ 2024-12-31
792023-01-01 ~ 2023-12-31
Wages/Salaries
6,299,195 GBP2024-01-01 ~ 2024-12-31
4,016,595 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
368,100 GBP2024-01-01 ~ 2024-12-31
250,198 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
7,262,487 GBP2024-01-01 ~ 2024-12-31
4,681,337 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
443,396 GBP2024-01-01 ~ 2024-12-31
-125,451 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Goodwill
16,850,810 GBP2024-12-31
10,466,145 GBP2023-12-31
Computer software
570,058 GBP2024-12-31
0 GBP2023-12-31
Patents/Trademarks/Licences/Concessions
14,147,719 GBP2024-12-31
10,568,462 GBP2023-12-31
Development expenditure
5,489,419 GBP2024-12-31
4,308,455 GBP2023-12-31
Intangible Assets - Gross Cost
40,020,290 GBP2024-12-31
27,981,937 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
6,864,973 GBP2024-12-31
5,345,477 GBP2023-12-31
Patents/Trademarks/Licences/Concessions
6,407,433 GBP2024-12-31
5,224,762 GBP2023-12-31
Development expenditure
920,686 GBP2024-12-31
1,963,827 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
15,893,386 GBP2024-12-31
14,096,944 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Goodwill
1,519,496 GBP2024-01-01 ~ 2024-12-31
Patents/Trademarks/Licences/Concessions
1,228,509 GBP2024-01-01 ~ 2024-12-31
Development expenditure
143,857 GBP2024-01-01 ~ 2024-12-31
Intangible Assets - Increase From Amortisation Charge for Year
3,050,172 GBP2024-01-01 ~ 2024-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
7,740,286 GBP2024-12-31
5,343,700 GBP2023-12-31
Development expenditure
4,568,733 GBP2024-12-31
2,344,627 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
137,124 GBP2024-12-31
101,880 GBP2023-12-31
Furniture and fittings
496,402 GBP2024-12-31
435,674 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
633,526 GBP2024-12-31
537,554 GBP2023-12-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
0 GBP2024-01-01 ~ 2024-12-31
Furniture and fittings
-1,989 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals
-1,989 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
65,589 GBP2024-12-31
41,181 GBP2023-12-31
Furniture and fittings
400,656 GBP2024-12-31
322,932 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
466,245 GBP2024-12-31
364,113 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
24,408 GBP2024-01-01 ~ 2024-12-31
Furniture and fittings
79,154 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
103,562 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
0 GBP2024-01-01 ~ 2024-12-31
Furniture and fittings
-1,430 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-1,430 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Plant and equipment
71,535 GBP2024-12-31
60,699 GBP2023-12-31
Furniture and fittings
95,746 GBP2024-12-31
112,742 GBP2023-12-31
Finished Goods/Goods for Resale
30,857,408 GBP2024-12-31
22,605,794 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
16,380,758 GBP2024-12-31
13,398,320 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
2,960,713 GBP2024-12-31
4,841,864 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
11,771,683 GBP2024-12-31
11,491,079 GBP2023-12-31
Other Debtors
Current
0 GBP2024-12-31
6,755 GBP2023-12-31
Prepayments/Accrued Income
Current
1,566,788 GBP2024-12-31
1,217,557 GBP2023-12-31
Trade Creditors/Trade Payables
Current
19,473,493 GBP2024-12-31
17,494,467 GBP2023-12-31
Amounts owed to group undertakings
Current
4,583 GBP2024-12-31
0 GBP2023-12-31
Other Taxation & Social Security Payable
Current
2,218,931 GBP2024-12-31
2,820,278 GBP2023-12-31
Other Creditors
Current
7,766,194 GBP2024-12-31
7,455,708 GBP2023-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
30,000 shares2024-12-31
30,000 shares2023-12-31
Par Value of Share
Class 2 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
70,002 shares2024-12-31
70,002 shares2023-12-31
Equity
Called up share capital
100,002 GBP2024-12-31
100,002 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
501,909 GBP2024-12-31
237,891 GBP2023-12-31
Between two and five year
1,089,673 GBP2024-12-31
691,175 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
1,591,582 GBP2024-12-31
929,066 GBP2023-12-31
Related profiles found in government register
  • ASPIRE PHARMA LIMITED
    Info
    Registered number 06828501
    icon of address102 High Street, Godalming, Surrey GU7 1DS
    Private Limited Company incorporated on 2009-02-24 (16 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-22
    CIF 0
  • ASPIRE PHARMA LIMITED
    S
    Registered number 06828501
    icon of address102, High Street, Godalming, England, GU7 1DS
    Private Limited Cpmpany in Companies House, England And Wales
    CIF 1
  • ASPIRE PHARMA LIMITED
    S
    Registered number 06828501
    icon of address102, High Street, Godalming, Surrey, England, GU7 1DS
    Private Limited Company in Companies House, England
    CIF 2 CIF 3
(more)
child relation
Offspring entities and appointments
Active 4
  • 1
    icon of addressElizabeth House, 13-19 London Road, Newbury, Berkshire, United Kingdom
    Active Corporate (4 parents)
    Equity (Company account)
    4,500 GBP2024-12-31
    Person with significant control
    icon of calendar 2024-03-07 ~ now
    CIF 4 - Right to appoint or remove directors → OE
    CIF 4 - Ownership of voting rights - 75% or more → OE
    CIF 4 - Ownership of shares – 75% or more → OE
  • 2
    icon of addressTrotwood The Firs, Odiham, Hook, Hampshire, England
    Active Corporate (4 parents)
    Equity (Company account)
    881,325 GBP2024-12-31
    Person with significant control
    icon of calendar 2025-10-01 ~ now
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of shares – 75% or more → OE
  • 3
    icon of address102 High Street, Godalming, Surrey, England
    Active Corporate (3 parents)
    Equity (Company account)
    100 GBP2024-12-31
    Person with significant control
    icon of calendar 2019-02-08 ~ now
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Ownership of shares – 75% or more → OE
  • 4
    icon of addressLinden House, Linden Close, Tunbridge Wells, Kent, United Kingdom
    Active Corporate (4 parents)
    Equity (Company account)
    305,040 GBP2025-06-30
    Person with significant control
    icon of calendar 2025-10-01 ~ now
    CIF 3 - Right to appoint or remove directors → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.